序号 | 标题 | 次数 | 作者 | 发布时间 |
---|---|---|---|---|
74116 | (S)-Deoxy-thalidomide-2,7-diazaspiro[3.5]nonane-CH2-Me-PIP-Boc | 62 | zyl | 2024-12-13 |
74117 | MC-VC-PABC-amide-PEG1-CH2-CC-885 | 53 | zyl | 2024-12-13 |
74118 | Azido-PEG4-(CH2)3OH | 65 | zyl | 2024-12-13 |
74119 | 慢病毒载体的来源及结构,构建慢病毒表达载体 | 798 | axc | 2024-12-13 |
74120 | Ald-CH2-PEG8-azide | 67 | zyl | 2024-12-13 |
74121 | m-PEG4-(CH2)6-Phosphonic acid | 71 | zyl | 2024-12-13 |
74122 | Ald-CH2-PEG5-Boc | 57 | zyl | 2024-12-13 |
74123 | 通过构建shRNA慢病毒质粒实现基因的敲减,慢病毒载体的发展过程 | 493 | axc | 2024-12-13 |
74124 | Fmoc-Gly-NH-CH2-O-Cyclopropane-CH2COOH | 68 | zyl | 2024-12-13 |
74125 | Gly-NH-CH2-Boc | 90 | zyl | 2024-12-13 |
74126 | Difluorocyclooctyne-CH2-benzoic acid | 87 | zyl | 2024-12-13 |
74127 | NH2-PEG2-CH2-Boc | 94 | zyl | 2024-12-13 |
74128 | shRNA慢病毒载体构建及细胞系筛选 | 414 | axc | 2024-12-13 |
74129 | Hydroxy-PEG4-(CH2)2-Boc | 73 | zyl | 2024-12-13 |
74130 | Thalidomide-5-O-CH2-COOH | 97 | zyl | 2024-12-13 |
74131 | Thalidomide-NH-CH2-COOH | 100 | zyl | 2024-12-13 |
74132 | Amino-PEG10-CH2-Boc | 106 | zyl | 2024-12-13 |
74133 | Hydroxy-PEG6-CH2-Boc | 61 | zyl | 2024-12-13 |
74134 | Tos-PEG4-CH2-Boc | 71 | zyl | 2024-12-13 |
74135 | m-PEG4-CH2-alcohol | 61 | zyl | 2024-12-13 |
74136 | β-Naphthoflavone-CH2-OH | 113 | zyl | 2024-12-13 |
74137 | 利用慢病毒快速构建IPS稳转株,定制服务 | 118 | axc | 2024-12-13 |
74138 | Methyl isonicotinate-(CH2)2-COOH | 67 | zyl | 2024-12-13 |
74139 | HO-PEG24-CH2COOtBu | 61 | zyl | 2024-12-13 |
74140 | Hydroxy-PEG10-CH2-Boc | 115 | zyl | 2024-12-13 |
74141 | Fmoc-Gly-NH-CH2-acetyloxy | 78 | zyl | 2024-12-13 |
74142 | Thalidomide-5-CH2-NH2 hydrochloride | 82 | zyl | 2024-12-13 |
74143 | MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH-d5 | 71 | zyl | 2024-12-13 |
74144 | 通过慢病毒介导的基因过表达,定制服务,实验步骤 | 121 | axc | 2024-12-13 |
74145 | 基因敲低、敲除、过表达载体的构建 | 1185 | axc | 2024-12-13 |
74146 | 质粒以及慢病毒的基因过表达方法 | 681 | axc | 2024-12-13 |
74147 | CRISPR KI技术构建基因过表达细胞株 | 186 | axc | 2024-12-13 |
74148 | CRISPRa系统构建基因过表达细胞株,CRISPRa技术优势 | 172 | axc | 2024-12-13 |
74149 | PB转座子系统构建基因过表达细胞,技术介绍 | 314 | axc | 2024-12-13 |
74150 | 慢病毒介导的稳定细胞株构建流程 | 477 | axc | 2024-12-13 |
74151 | 慢病毒载体介导过表达和敲低细胞株的建立 | 228 | axc | 2024-12-13 |
74152 | 七肽DOTA-YLYEIAR,1262403-90-6 | 111 | h | 2024-12-12 |
74153 | DOTA-CH2-Ph-azide(HCl salt) | 138 | h | 2024-12-12 |
74154 | NOTA-PEG-TAT,大环配体NOTA-聚乙二醇-TAT | 91 | h | 2024-12-12 |
74155 | DOTA-Lys-Cys-Acid,1180007-00-4 | 111 | h | 2024-12-12 |
74156 | DOTA-NHS ester,CAS170908-81-3 | 84 | h | 2024-12-12 |
74157 | C18-PEG-Lactoferrin; 十八烷基-聚乙二醇-乳铁蛋白 | 298 | kx | 2024-12-12 |
74158 | C18-PEG-Glucose ;十八烷基-聚乙二醇-葡萄糖 | 151 | kx | 2024-12-12 |
74159 | C18-PEG-NPC ;十八烷基-聚乙二醇-NPC | 141 | kx | 2024-12-12 |
74160 | 1262403-92-8,十三肽DOTA-LGEYGFQNALIVR | 92 | h | 2024-12-12 |